Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06183307

Effects of Nattokinase on Inflammation and Cardiovascular Risk Markers in Patients With Dyslipidemia

Led by Universidade Federal Fluminense · Updated on 2026-05-14

48

Participants Needed

1

Research Sites

124 weeks

Total Duration

On this page

Sponsors

U

Universidade Federal Fluminense

Lead Sponsor

C

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Collaborating Sponsor

AI-Summary

What this Trial Is About

The study aims to evaluate the effect of the nattokinase enzyme on inflammation and markers of cardiovascular risk in participants with dyslipidemia. A longitudinal double-blind randomized clinical trial will be carried out, involving hypertensive participants with dyslipidemia for two months.

CONDITIONS

Official Title

Effects of Nattokinase on Inflammation and Cardiovascular Risk Markers in Patients With Dyslipidemia

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Both sexes
  • Age 18 years or older
  • Isolated increase in LDL cholesterol (LDL-c 260 mg/dL)
  • Isolated increase in triglycerides (TG 250 mg/dL or 275 mg/dL without fasting)
  • Reduced HDL cholesterol (men < 40 mg/dL, women < 50 mg/dL) alone or with increased LDL-c or TG
  • Individuals using lipid-lowering therapy (statins or non-statins)
Not Eligible

You will not qualify if you...

  • Autoimmune and infectious diseases, diabetes, cancer, or AIDS
  • Pregnant women
  • Use of catabolic drugs or antibiotics
  • Use of anticoagulant medication
  • Use of antioxidant vitamin supplements, prebiotic, probiotic, or synbiotic
  • Allergic to corn or soy starch

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Denise Mafra

Rio de Janeiro, Rio de Janeiro, Brazil, 22260050

Actively Recruiting

Loading map...

Research Team

D

Denise Mafra, PhD

CONTACT

L

Ludmila Cardozo, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Effects of Nattokinase on Inflammation and Cardiovascular Risk Markers in Patients With Dyslipidemia | DecenTrialz